Results for tag: "Radiocontrast Media"

Radiocontrast media, also known as contrast media, are substances used to enhance the visibility of internal structures in medical imaging. Contrast media are used in X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound imaging. They are administered intravenously, orally, or rectally, depending on the type of imaging procedure. Contrast media are typically composed of iodine, barium, or gadolinium, and are used to improve the visibility of organs, vessels, and tissues. The radiocontrast media market is driven by the increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, and the growing demand for advanced imaging techniques. The rising number of diagnostic imaging procedures and the increasing adoption of minimally invasive procedures are also contributing to the growth of the market. Some of the major companies in the radiocontrast media market include Bayer AG, Bracco Imaging S.p.A., Guerbet Group, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, and Merck KGaA. Show Less Read more